Lonza has acquired Redberry SAS for an undisclosed amount, integrating the French company's rapid microbial detection technology. This acquisition marks a strategic expansion for Lonza into advanced quality control solutions. Redberry specializes in innovative rapid testing solutions designed to bypass the traditional culture phase for microorganisms in industrial microbiology, delivering immediate results with high performance, cost-effectiveness, and user ease.
Redberry's flagship Red One™ platform provides instantaneous microbial detection, offering rapid screening in minutes, bioburden enumeration in hours, and sterility testing within days. These applications are critical for quality control across various sectors, including pharmaceuticals (covering small molecules, large molecules, advanced therapy medicinal products, mRNA, and standard products), personal care products, and water management (for in-process, raw materials, final products, and water loops). The technology allows for precise, real-time detection of single cells, addressing a significant need for accelerated testing protocols.
For Lonza, a global partner to the pharmaceutical, biotech, and nutrition industries, the acquisition of Redberry SAS is a move to enhance its capabilities in microbial quality control and assurance. Redberry's technologies are expected to complement Lonza's extensive manufacturing and development services by providing faster, more efficient microbial monitoring across its operations. This integration aims to streamline production processes, accelerate product release, and bolster overall product safety and compliance for Lonza and its clients.
The synergy between the two companies is anticipated to lead to improved operational efficiencies and a strengthened competitive position for Lonza. By incorporating Redberry's rapid detection solutions, Lonza can offer its clients enhanced quality assurance, faster turnaround times for critical analyses, and potentially new services built around advanced microbial monitoring. This will benefit manufacturers needing quick and reliable microbiological data for their products and processes, solidifying Lonza's position in comprehensive life cycle solutions.